Alzheimer's
The CCE platform gives primary care, specialists and researchers an accurate digital cognitive evaluation and brings visibility to early cognitive impairment.
The mobile app-based AI has 87% accuracy in identifying Alzheimer's disease.
It will validate BrainEye's 60-second eye movement test to about 500 participants.
Its AI model can predict the accumulation of amyloid-beta protein, a major Alzheimer's biomarker.
They are also considering developing a senior care service leveraging AI.
Fake MRIs generated using AI were used to check the sensitivity of existing measures of brain atrophy.
Also, a new AI-powered health supplement app has gone live in South Korea.
The National Institute on Aging will utilize Ro's telehealth platform to screen and recruit patients at elevated risk for developing Alzheimer's disease or other related dementia.
GP who advised on controversial NHS data sharing plan receives damehood.
The company said the Series B brings its total raise to $20 million.